文献速递慢性肾脏病遗传性与小管间质肾病

不明原因慢性肾脏病(CKDu)的管理建议

Chronic kidney disease of unknown origin - management proposal.
PubMed 文献 · Nephrol Dial Transplant · 2026-09-09

本文针对中美洲、斯里兰卡和印度农村社区聚集性发生的不明原因慢性肾脏病(CKDu),综述其病理特征与潜在病因,提出个体管理可参考非白蛋白尿性CKD人群的随机对照试验亚组数据,社区层面干预则基于热应激与饮水相关项目的pre-post证据,并指出研究空白与优先方向。

要点

  • CKDu患者常无传统代谢或血管危险因素,肾功能下降但无明显蛋白尿。
  • 病理以肾小管间质炎症纤维化及无免疫复合物沉积的肾小球硬化为特征。
  • 个体管理借鉴非白蛋白尿性CKD的RCT亚组数据,社区干预证据多来自非随机pre-post评估。

核心结论

  • CKDu缺乏特异性诊断生物标志物和专项随机试验,管理需借鉴非白蛋白尿性CKD人群证据。
  • 社区或职业层面的预防干预(如休息-饮水-遮阴、安全饮水)是CKDu防控的重要方向。

研究设计与样本

  • 本文为管理建议性综述,未报告系统检索范围与样本量。
  • 个体管理证据来自大型CKD随机对照试验和meta分析的亚组数据,选取非白蛋白尿性CKD为最相关表型。
  • 社区干预证据来自流行区休息-饮水-遮阴及安全饮用水项目的pre-post数据。

主要发现

  • CKDu影响中美洲、斯里兰卡和印度农村社区聚集人群,患者可缺乏常规代谢或血管危险因素。
  • 病理显示肾小管间质炎症和纤维化程度不一,肾小球硬化但无免疫复合物沉积。
  • 尚无验证的CKDu诊断生物标志物,肾小管损伤和炎症标志物正在研究中。
  • 主要病因假说包括反复热应激、农药暴露、二氧化硅纳米颗粒、地下水污染、感染和遗传易感性。

临床怎么用

  • 对无传统危险因素、无显著蛋白尿的肾功能下降患者,应考虑CKDu可能。
  • 个体管理可参考非白蛋白尿性CKD人群的RCT亚组证据以延缓进展。
  • 在流行区可推动休息-饮水-遮阴和安全饮用水等社区层面预防措施。

局限性

  • CKDu特异性随机对照试验缺乏,个体管理证据为间接外推。
  • 社区干预证据 largely 限于非随机pre-post评估。
  • 诊断生物标志物未经验证,病因假说未确立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease of unknown etiology (CKDu) affects residents of distinct clusters of rural communities in Central America, Sri Lanka, and India. Affected persons may lack conventional metabolic or vascular risk factors for CKD and present with declining kidney function in the absence of significant proteinuria. The precise pathogenesis remains uncertain, with leading hypotheses including recurrent heat stress, agrochemical exposure, silica nanoparticles, contaminated groundwater, infections, and genetic susceptibility. Histopathology demonstrates varying levels of inflammation and fibrosis in the tubulo-interstitial compartment, and glomerulosclerosis without immune-complex deposition. No validated biomarker exists for diagnosis of CKDu, although tubular injury and inflammatory markers are under study. Interventions in CKDu can target the mitigation of disease progression, but also, notably, interventions at a community or occupation level could be preventive, since the list of hypothesized causes are primarily community or occupation-based exposures. In the absence of CKDu-specific trials, to aid management at the individual level, we review the subgroup data from large, randomized control trials and meta-analyses in CKD populations. We selected the non-albuminuric CKD population as the closest relevant phenotype with available individual level data to inform the proposed management standard. Although randomized trials may be feasible for some community-based interventions, available evidence is largely limited to non-randomized evaluations; we therefore review the pre-post data from programs on rest-water-shade and provision of safe drinking water in endemic regions. We also highlight key knowledge gaps and research priorities in CKDu management and prevention, and review ongoing studies that may inform future evidence-based prevention and treatment strategies.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Nieves MC, Nanayakkara N, Garcia-Trabanino R, et al. Chronic kidney disease of unknown origin - management proposal. Nephrol Dial Transplant. 2026. PMID: 42714830. doi:10.1093/ndt/gfag196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。